Journal article

Antibodies to the Plasmodium falciparum Proteins MSPDBL1 and MSPDBL2 Opsonize Merozoites, Inhibit Parasite Growth, and Predict Protection from Clinical Malaria

CYH Chiu, AN Hodder, CS Lin, DL Hill, CSN Li Wai Suen, L Schofield, PM Siba, I Mueller, AF Cowman, DS Hansen

Journal of Infectious Diseases | Published : 2015

Abstract

Increasing evidence suggests that antibodies against merozoite surface proteins (MSPs) play an important role in clinical immunity to malaria. Two unusual members of the MSP-3 family, merozoite surface protein duffy binding-like (MSPDBL)1 and MSPDBL2, have been shown to be extrinsically associated to MSP-1 on the parasite surface. In addition to a secreted polymorphic antigen associated with merozoite (SPAM) domain characteristic of MSP-3 family members, they also contain Duffy binding-like (DBL) domain and were found to bind to erythrocytes, suggesting that they play a role in parasite invasion. Antibody responses to these proteins were investigated in a treatment-reinfection study conducte..

View full abstract

Grants

Awarded by National Health and Medical Research Council


Awarded by National Health and Medical Research Council of Australia


Funding Acknowledgements

The work was supported by the Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme and National Health and Medical Research Council (project grants 1031212 and 1058665). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.